Everfront Ventures Corp. (CVE:EVC), an artificial intelligence stock, climbed after announcing that it has acquired Nexalogy Environics
Sean Mason | September 25, 2017 | SmallCapPower
A big bet on AI had more than a few speculators buzzing over an artificial intelligence stock Monday. Here’s some small stocks making big moves on Monday, September 25, 2017 (as of 4 pm EST):
Everfront Ventures Corp. (TSXV: EVC), an artificial intelligence stock, jumped as much as 12% before ending up 4% at $0.135 on Monday after announcing that it has acquired Nexalogy Environics, a business intelligence and data analysis provider through its artificial intelligence platform to government agencies and Fortune 500 corporations. The purchase price of $6 million consists of cash and Everfront Ventures stock.
As well, shares of Titan Medical Inc. (TSX: TMD) climbed 9% to $0.245 as the medical device company said it has successfully completed the world’s first gynecologic, colorectal and urologic single port robotic procedures using its advanced prototype SPORT Surgical System at the Florida Hospital Nicholson Center in Celebration, Florida.
Novo Resources Corp. (TSXV: NVO), meanwhile, reported that its President and Chairman, Dr. Quinton Hennigh, will be discussing the Company’s exploration plans at the Denver Gold Forum today. Novo Resources stock moved up 27% to $6.50 following the announcement.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
Disclosure: Neither the author nor any of the principals at SmallCapPower, or their family members, own shares in any of the companies mentioned above.
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below: